SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-21-007275
Filing Date
2021-03-31
Accepted
2021-03-31 13:47:36
Documents
1
Period of Report
2021-03-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 2697
  Complete submission text file 0001567619-21-007275.txt   4355
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Issuer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 227 WASHINGTON STREET SUITE 200 CONSHOHOCKEN PA 19428
Business Address
McLaughlin Gerald W. (Reporting) CIK: 0001495412 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38247 | Film No.: 21792318